• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Indonesia·Basic Materials·JARR.JK
Share

PT Jhonlin Agro Raya Tbk Stocks

IDR 1915Last Updated 07.08.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

IDR 1.07B

IDR 1915
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

PT Jhonlin Agro Raya Tbk is an Indonesian enterprise primarily engaged in the cultivation of oil palm. Its operations are organized into two principal divisions: Fatty Acid Methyl Ester and Fresh Fruit Bunches. The company manages a substantial 20,000-hectare portfolio of oil palm estates located across the Tanah Bumbu and Kotabaru Regencies within South Kalimantan province. In addition to its core agricultural activities, it is involved in plasma plantation initiatives and the creation of biodiesel. Founded in 2014 and with its headquarters in Tanah Bumbu, Indonesia, PT Jhonlin Agro Raya Tbk operates as a subsidiary of PT Eshan Agro Sentosa.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

08.08.2026 12:15

Ukraine has promised the U.S. not to attack the CPC infrastructure in the Black Sea — Bloomberg

08.08.2026 03:20

Billionaire Ekman Identified the Main Risk for Investors in the Anthropic and OpenAI IPOs

08.08.2026 02:52

U.S. stocks posted their best weekly gain since mid-April. The S&P 500 hit a new record high.

08.08.2026 02:36

OpenAI has suspended development of a new AI model due to cybersecurity risks

08.08.2026 01:46

The U.S. Senate has approved new sanctions against Russia. It may be difficult for the bill to pass the full Congress.

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026